Magnum Ice Cream gets mixed review from investment bank analysts

Magnum Ice Cream (MICC) opened as a standalone listed business with a market cap of €7.9bn after closing its first session at 1,122.4p (€13) and was trading down about 2% at 1,100.4p as analysts issued mixed verdicts: UBS initiated with a Buy and €14.3 target, forecasting 3.2% medium‑term organic growth, margin expansion from 2027 and meaningful free cash flow from 2028 (noting risks from healthier eating, GLP‑1 drugs and regulation and a potential cocoa-driven gross‑margin tailwind in late‑2026); JPMorgan started Neutral with a €14 target, pencilling in 2.9% like‑for‑like sales in FY26 and warning that early ramp‑up costs, India consolidation and transition services with Unilever will weigh on 2025/26 margins and cash flow. Both banks see MICC trading roughly in line with European food & beverage peers (UBS implies 2026 EV/EBITDA 9.3x; JPMorgan implies 2027 earnings 11.3x and EV/EBITDA 7.4x), leaving upside contingent on execution against near‑term cost and growth headwinds.

Analysis

Magnum Ice Cream began trading as a standalone listed business at 1,122.4p (€13) with a market capitalisation of €7.9bn and was trading down about 2% at 1,100.4p as brokers issued divergent initial views. UBS initiated coverage with a Buy and a €14.3 price target, projecting medium‑term organic sales growth of 3.2% (at the low end of management’s 3–5% target), margin expansion from 2027 and “meaningful” free cash flow expected from 2028, while flagging risks from healthier‑eating trends, weight‑loss drugs and regulation. JPMorgan started Neutral with a €14 target, forecasting 2.9% like‑for‑like sales in FY26 and warning that ramp‑up costs, India consolidation and transition services with former parent Unilever will depress 2025/26 margins and cash flow, leaving 2026 at the bottom of medium‑term targets. Both houses place MICC roughly in line with European food & beverage peers (UBS implies 2026 EV/EBITDA 9.3x; JPMorgan implies 2027 P/E 11.3x and EV/EBITDA 7.4x), so near‑term upside is contingent on visible execution of cost savings, transition exits and commodity tailwinds noted by UBS.

Key Decisions for Investors

• Consider a selective, size‑controlled position to capture potential re‑rating if MICC delivers 2027 margin gains and the 2028 free cash‑flow inflection,
• Monitor key near‑term indicators — FY26 like‑for‑like sales, margin trajectory, costs from India consolidation, progress exiting transition service agreements and cocoa price movements — before increasing exposure,
• Maintain a neutral or hedged stance ahead of 2025/26 results given JPMorgan’s view that early‑stage costs will back‑end delivery and could pressure cash flow,
• Use peer valuation bands (UBS 2026 EV/EBITDA 9.3x; JPMorgan 2027 P/E 11.3x, EV/EBITDA 7.4x) as triggers to trim or add positions depending on execution versus guidance